|
Study evaluating in healthy children safety and immunogenicity of GSK Bios' combined Measles-Mumps-Rubella-Varicella vaccine, compared to GSK Bios' Varicella and Measles-Mumps-Rubella vaccines admind as separate injections |
Combined Measles, Mumps, Rubella, Varicella Vaccine |
208136/006 (MeMuRu-OKA-006) |
|
Measles; Mumps; Rubella; Varicella |
Phase 2 |
|
|
|
|
An annotated case report form is not available for this study. A blank case report form will be provided. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
September 2015 |